World's Best Scientists 2026 revealed!
Stefano Del Prato

Stefano Del Prato

D-Index & Metrics

Medicine

D-Index
97
Citations
45831
World Ranking
9120
National Ranking
314

Stefano Del Prato publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stefano Del Prato sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 671 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stefano Del Prato D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stefano Del Prato sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stefano Del Prato is affiliated with the University of Pisa in Italy and has an extensive publication record in the field of medicine, focusing primarily on endocrinology, diabetes, and metabolism. Their research contributions cover a wide spectrum of topics centered on diabetes treatment, management, and associated metabolic conditions.

Their work spans multiple subfields including endocrinology, diabetes and metabolism, surgery, molecular biology, cardiology and cardiovascular medicine, and physiology. Major thematic areas in their publications include diabetes treatment and management, diabetes management and research, metabolism related to diabetes and cancer, pancreatic function and diabetes, diet and metabolism studies, diabetes and associated disorders, and cardiovascular function and risk factors.

Stefano Del Prato has frequently published in the following venues:

  • Diabetes
  • Diabetes Care
  • Diabetes Obesity and Metabolism
  • Diabetologia
  • Diabetes Research and Clinical Practice

Their research collaborations include frequent co-authorships with Julio Rosenstock, Cristina Bianchi, Giuseppe Penno, Monia Garofolo, and Carolyn S.P. Lam.

Key papers associated with Stefano Del Prato include:

  • Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), 2022, Diabetes Care
  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials, 2021, The Lancet Diabetes & Endocrinology
  • COVID-19 in people with diabetes: understanding the reasons for worse outcomes, 2020, The Lancet Diabetes & Endocrinology
  • Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), 2022, Diabetologia
  • New-Onset Diabetes in Covid-19, 2020, New England Journal of Medicine

Best Publications

  • Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

    Steven E Kahn;Mark E Cooper;Stefano Del Prato

  • Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: a Joint Statement by International Diabetes Organizations.

    Francesco Rubino;David M Nathan;Robert H Eckel;Philip R Schauer

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • How Do We Define Cure of Diabetes

    John B. Buse;Sonia Caprio;William T. Cefalu;Antonio Ceriello

  • Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations

    Francesco Rubino;David M. Nathan;Robert H. Eckel;Philip R. Schauer

  • Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes

    Valeriya Lyssenko;Roberto Lupi;Piero Marchetti;Silvia Del Guerra

  • COVID-19 in people with diabetes: understanding the reasons for worse outcomes.

    Matteo Apicella;Maria Cristina Campopiano;Michele Mantuano;Laura Mazoni

  • Prolonged Exposure to Free Fatty Acids Has Cytostatic and Pro-Apoptotic Effects on Human Pancreatic Islets: Evidence that β-Cell Death Is Caspase Mediated, Partially Dependent on Ceramide Pathway, and Bcl-2 Regulated

    Roberto Lupi;Francesco Dotta;Lorella Marselli;Silvia Del Guerra

  • Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

    Naveed Sattar;Matthew M Y Lee;Søren L Kristensen;Kelley R H Branch

  • New-Onset Diabetes in Covid-19.

    Francesco Rubino;Stephanie A. Amiel;Paul Zimmet;K. George M. M. Alberti

  • Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients

    Francesco Dotta;Stefano Censini;Astrid G. S. van Halteren;Lorella Marselli

  • Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin: A randomized, 52-week, double-blind, active-controlled noninferiority trial

    Michael A. Nauck;Stefano Del Prato;Juris J. Meier;Santiago Durán-García

  • Management of type 2 diabetes: new and future developments in treatment.

    Abd A Tahrani;Abd A Tahrani;Clifford J Bailey;Stefano Del Prato;Anthony H Barnett;Anthony H Barnett

  • Functional and Molecular Defects of Pancreatic Islets in Human Type 2 Diabetes

    Silvia Del Guerra;Roberto Lupi;Lorella Marselli;Matilde Masini

  • Obesity and insulin resistance in humans: A dose-response study☆

    Riccardo C. Bonadonna;Groop Leif;Nancy Kraemer;Eleuterio Ferrannini

  • Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.

    Hertzel C. Gerstein;Naveed Sattar;Julio Rosenstock;Chinthanie Ramasundarahettige

  • Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man.

    S. Del Prato;F. Leonetti;D. C. Simonson;P. Sheehan

  • Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

    Piero Marchetti;Silvia Del Guerra;Lorella Marselli;Roberto Lupi

  • Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial

    Alan J Garber;Allen B King;Stefano Del Prato;Seamus Sreenan

  • Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

    Stefano Del Prato;Steven E Kahn;Imre Pavo;Govinda J Weerakkody

Frequent Co-Authors

Piero Marchetti
Piero Marchetti University of Pisa
Julio Rosenstock
Julio Rosenstock The University of Texas Southwestern Medical Center
Enzo Bonora
Enzo Bonora University of Verona
Giorgio Sesti
Giorgio Sesti Sapienza University of Rome
Itamar Raz
Itamar Raz Hebrew University of Jerusalem
Ralph A. DeFronzo
Ralph A. DeFronzo The University of Texas Health Science Center at San Antonio
Lawrence A. Leiter
Lawrence A. Leiter University of Toronto
Angelo Avogaro
Angelo Avogaro University of Padua
Robert R. Henry
Robert R. Henry University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Medicine or want to supplement your medical education, there are several flexible online pathways to advance your qualifications. For those who are already licensed nurses, enrolling in the shortest dnp programs can expedite your journey towards advanced practice and leadership roles. These programs are designed to be intensive yet efficient, allowing you to earn a Doctor of Nursing Practice degree quickly.

For students seeking a more accessible route, dnp programs online offer flexible schedules, making advanced education possible alongside professional and personal commitments. These programs are well-suited for nurses looking to enhance their clinical expertise with minimal disruption to their work-life balance.

If you’re at the start of your nursing journey, fast track lpn programs provide a quick entry-point into healthcare, enabling you to gain hands-on experience and enter the workforce sooner.

Specializing further, the fastest online pmhnp programs allow qualified nurses to focus on psychiatric mental health, addressing an urgent need in today’s healthcare landscape. These online options combine speed with quality and flexibility, making them ideal for today’s aspiring healthcare professionals.

Best Scientists Citing Stefano Del Prato

Trending Scientists

Recently Published Articles